EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALS (Q27322781)
scientific article published on April 26, 2013
Language:
(P31) (Q13442814)
(P50) (Q87191291)
(P275) (Q20007257)
(P304) e62342
(P407) (Q1860)
(P433) 4
(P478) 8
(P577) +2013-00-00T00:00:00Z
Friday, April 26, 2013
(P921) (Q206901)
(Q418369)
(P953) https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0062342&type=printable
https://europepmc.org/articles/PMC3637182
https://europepmc.org/articles/PMC3637182?pdf=render
http://dx.plos.org/10.1371/journal.pone.0062342
(P1433) (Q564954)
(P1476) "EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS" (language: en)
"EGFR Inhibitor Erlotinib Delays Disease Progression but Does Not Extend Survival in the SOD1 Mouse Model of ALS" (language: en)
(P2093) Hilda Solanoy
Hai Ngu
Nicholas Lewin-Koh
Mark Chen
Ryan Watts
Kimberly Scearce-Levie
Claire E. Le Pichon
Sara L. Dominguez
(P2860) (Q24201081)
(Q27345515)
(Q26253934)
(Q27863362)
(Q28139487)
(Q28268686)
(Q28264038)
(Q28509173)
(Q28581302)
(Q29547561)
(Q29617451)
(Q36344611)
(Q35949689)
(Q37642283)
(Q34311374)
(Q40551071)
(Q46310473)
(Q45923964)
(Q47951637)
(Q48474166)
(Q44538961)
(Q49045082)
(Q50494832)
(Q80572194)
(Q80590602)
(Q73091505)
(Q83940098)
(Q83255580)
(Q83959178)
(P6216) (Q50423863)
other details
description scientific article published on April 26, 2013

External Links